Search results
IARC group 2B substances, mixtures and exposure circumstances are those that have been classified as "possibly carcinogenic to humans" by the International Agency for Research on Cancer (IARC) as This category is used when there is limited evidence of carcinogenicity in humans and less than sufficient evidence of carcinogenicity in experimental animals.
Grade 1: Cancer-causing substances with evidence supporting carcinogenicity in humans. Eg: asbestos, processed meats, smoking; Grade 2: Substances that are probably carcinogenic to humans. 2A: Grade 2 substances with sufficient evidence of carcinogenicity in animals and limited evidence in humans. This includes DDT, red meat, working night ...
Jul 1, 2011 · The authors quote correctly that the ‘International Agency for Research on Cancer (IARC) classified styrene as possibly carcinogenic to humans (Group 2B) and SO as probably carcinogenic to humans (Group 2A)’. IARC’s evaluation of the available human studies nearly 10 years ago stated ‘There is limited evidence in humans for the ...
Nov 14, 2023 · A Working Group of 30 international experts from 11 countries was convened by the IARC Monographs programme for a meeting on 7–14 November 2023 in Lyon. After thoroughly reviewing the extensive published literature, the Working Group classified PFOA as carcinogenic to humans (Group 1) and PFOS as possibly carcinogenic to humans (Group 2B).
The International Agency for Research on Cancer (IARC), which is the specialized cancer agency of the World Health Organization, has declared aspartame may be a possible carcinogenic hazard to humans.
Feb 24, 2015 · The IARC Monographs on the Evaluation of Carcinogenic Risks to Humans of the International Agency for Research on Cancer (IARC) are a prominent example of such an expert review process. The goal of the Monograph Programme is to assess carcinogenic hazards from occupational, environmental, and lifestyle exposures and agents, thus providing an ...
classifi ed as probably carcinogenic or possibly carcinogenic to humans. In most cases, the cancer site associations are clear and are based on the published summary and evaluation by the most recent Working Group that has classifi ed an agent. For some agents with positive fi ndings for several cancer sites, we made a judgment
